IGMS Jun 2024 5.000 call
OPR - OPR Delayed Price. Currency in USD
Add to watchlist
As of 12:32PM EDT. Market open.
Loading interactive chart...
- Simply Wall St.
Shareholders May Find It Hard To Justify Increasing IGM Biosciences, Inc.'s (NASDAQ:IGMS) CEO Compensation For Now
Key Insights IGM Biosciences' Annual General Meeting to take place on 11th of June Salary of US$646.8k is part of CEO...
- Simply Wall St.
We're Keeping An Eye On IGM Biosciences' (NASDAQ:IGMS) Cash Burn Rate
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
- GlobeNewswire
IGM Biosciences to Present at the Jefferies Healthcare Conference
MOUNTAIN VIEW, Calif., May 29, 2024 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company creating and developing engineered IgM antibodies, today announced that Fred Schwarzer, Chief Executive Officer, will participate in a fireside chat at the Jefferies Healthcare Conference on Wednesday, June 5, 2024, at 2:30 p.m. EDT in New York. A live webcast of the event will be available on the “Events and Presentations” page in the “Investors” section of the Co
© 2024 Yahoo. All rights reserved.